Insider Trades21 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Buy | AVIR | Andrea Corcoran | — | 60,000 | $1.24 | $389.7M | -24.50% | +75.18% | $74.4K | +7.86% | — | Trim |
| Jan 31, 2026 | Sell | AVIR | John Vavricka | Chief Commercial Officer | 11,570 | $4.24 | $389.7M | -24.50% | +75.18% | $49.1K | -5.41% | — | Trim |
| Jan 31, 2026 | Sell | AVIR | Wayne Foster | EVP, Chief Accounting Officer | 12,132 | $4.24 | $389.7M | -24.50% | +75.18% | $51.4K | -6.08% | — | Trim |
| Jan 31, 2026 | Sell | AVIR | Janet Mj Hammond | Chief Development Officer | 14,136 | $4.24 | $389.7M | -24.50% | +75.18% | $59.9K | -4.43% | — | Trim |
| Jan 31, 2026 | Sell | AVIR | Maria Arantxa Horga | Chief Medical Officer | 16,073 | $4.24 | $389.7M | -24.50% | +75.18% | $68.1K | -5.63% | — | Trim |
| Jan 31, 2026 | Sell | AVIR | Andrea Corcoran | — | 16,104 | $4.24 | $389.7M | -24.50% | +75.18% | $68.3K | -1.68% | — | Trim |
| Jan 31, 2026 | Buy | AVIR | Jean-Pierre Sommadossi | President, CEO, and Chairman | 406,093 | $2.02 | $389.7M | -24.50% | +75.18% | $821.8K | +18.61% | — | Trim |
| Jan 31, 2025 | Sell | AVIR | John Vavricka | Chief Commercial Officer | 11,517 | $3.06 | $389.7M | -24.50% | +75.18% | $35.2K | -4.83% | — | Trim |
| Jan 31, 2025 | Sell | AVIR | Wayne Foster | EVP, Chief Accounting Officer | 12,062 | $3.06 | $389.7M | -24.50% | +75.18% | $36.9K | -5.39% | — | Trim |
| Jan 31, 2025 | Sell | AVIR | Janet Mj Hammond | Chief Development Officer | 14,134 | $3.06 | $389.7M | -24.50% | +75.18% | $43.3K | -4.00% | — | Trim |
| Jan 31, 2025 | Sell | AVIR | Maria Arantxa Horga | Chief Medical Officer | 16,071 | $3.06 | $389.7M | -24.50% | +75.18% | $49.2K | -5.01% | — | Trim |
| Jan 31, 2025 | Sell | AVIR | Andrea Corcoran | — | 16,102 | $3.06 | $389.7M | -24.50% | +75.18% | $49.3K | -1.63% | — | Trim |
| Jan 31, 2025 | Sell | AVIR | Jean-Pierre Sommadossi | President, CEO, and Chairman | 88,601 | $3.06 | $389.7M | -24.50% | +75.18% | $271.1K | -8.04% | — | Trim |
| Sep 17, 2024 | Sell | AVIR | Jean-Pierre Sommadossi | President, CEO, and Chairman | 57,969 | $4.04 | $389.7M | -24.50% | +75.18% | $234.2K | -0.33% | — | Trim |
| Jun 5, 2024 | Sell | AVIR | Jean-Pierre Sommadossi | President, CEO, and Chairman | 1,006 | $4.00 | $389.7M | -24.50% | +75.18% | $4.0K | -0.02% | — | Trim |
| Feb 1, 2024 | Sell | AVIR | John Vavricka | Chief Commercial Officer | 11,819 | $3.84 | $389.7M | -24.50% | +75.18% | $45.4K | -5.08% | — | Trim |
| Feb 1, 2024 | Sell | AVIR | Wayne Foster | EVP, Chief Accounting Officer | 12,477 | $3.84 | $389.7M | -24.50% | +75.18% | $47.9K | -5.67% | — | Trim |
| Feb 1, 2024 | Sell | AVIR | Janet Mj Hammond | Chief Development Officer | 14,029 | $3.84 | $389.7M | -24.50% | +75.18% | $53.9K | -3.81% | — | Trim |
| Feb 1, 2024 | Sell | AVIR | Andrea Corcoran | — | 15,843 | $3.84 | $389.7M | -24.50% | +75.18% | $60.9K | -1.63% | — | Trim |
| Feb 1, 2024 | Sell | AVIR | Maria Arantxa Horga | Chief Medical Officer | 15,870 | $3.84 | $389.7M | -24.50% | +75.18% | $61.0K | -5.00% | — | Trim |
| Feb 1, 2024 | Sell | AVIR | Jean-Pierre Sommadossi | President, CEO, and Chairman | 56,910 | $3.85 | $389.7M | -24.50% | +75.18% | $218.8K | -5.88% | — | Trim |